All Stories

  1. The Novel Antipsychotic Drug Cariprazine and Cognition Enhancing Drugs: Indications for their Use as the Add-on Therapy in Schizophrenia

    Article • Current Pharmaceutical Design, October 2021, Bentham Science Publishers

    Dr Felix-Martin Werner

  2. Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic Treatment

    Article • Current Pharmaceutical Design, August 2021, Bentham Science Publishers

    Dr Felix-Martin Werner

  3. Importance of Risk Genes in Neurological and Psychiatric Diseases and the Influence of the Function of These Risk Genes for Choosing the Appropriate Pharmacotherapy

    Article • Current Pharmaceutical Design, August 2021, Bentham Science Publishers

    Dr Felix-Martin Werner

  4. Neural Networks in Generalized Epilepsy and Novel Antiepileptic Drugs

    Article • Current Pharmaceutical Design, June 2019, Bentham Science Publishers

    Dr Felix-Martin Werner

  5. Therapeutic Effect of Novel Antidepressant Drugs Acting at Specific Receptors of Neurotransmitters and Neuropeptides

    Article • Current Pharmaceutical Design, June 2019, Bentham Science Publishers

    Dr Felix-Martin Werner

  6. Neural Networks in Neurological and Psychiatric Diseases

    Article • Current Pharmaceutical Design, June 2019, Bentham Science Publishers

    Dr Felix-Martin Werner

  7. Influence of sustance and drug abuse on the disease outcome in schizophrenia

    Article • Current Drug Abuse Reviews, June 2018, Bentham Science Publishers

    Dr Felix-Martin Werner

  8. Serotonergic alterations and dysfunction of other neurotransmitters in Alzheimer's disease

    Article • Current Pharmaceutical Design, April 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  9. How to Choose an Appropriate Prophylactic Drug

    Article • February 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  10. Classical Neurotransmitters and Neuropeptides Involved in Schizoaffective Disorder

    Article • February 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  11. Preface

    Article • February 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  12. Conclusion

    Article • February 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  13. Subject Index

    Article • February 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  14. Forms of Schizoaffective Disorder and Case Reports

    Article • February 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  15. Function of Susceptibility Genes

    Article • February 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  16. Neural Networks in Schizoaffective Disorder

    Article • February 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  17. Current Pharmacotherapy in the Treatment of Schizoaffective Disorder

    Article • February 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  18. Classical Neurotransmitters and Neuropeptides Involved in Schizoaffective Disorder: Focus on Prophylactic Medication

    Article • February 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  19. Schizoaffective Disorder: Alterations of Neurotransmitters and Neuropeptides in Brain Centers Involved in Psychotic and Affective Symptoms

    Article • February 2016, Bentham Science Publishers

    Dr Felix-Martin Werner

  20. Additional Antidepressant Pharmacotherapies According to a Neural Network

    Article • Brain Disorders & Therapy, January 2016, OMICS Publishing Group

    Dr Felix-Martin Werner

  21. Symptoms and Therapeutic Options of the Anti-NMDA Receptor Encephalitis According To a Neural Network

    Article • Anatomy & Physiology, January 2016, OMICS Publishing Group

    Dr Felix-Martin Werner

  22. Pharmacological options in the treatment of antipsychotic-induced extrapyramidal symptoms

    Article • Journal of Cytology & Histology, January 2016, OMICS Publishing Group

    Dr Felix-Martin Werner

  23. Treatment of Dementia in Parkinsonian Patients

    Article • Journal of Gerontology & Geriatric Research, January 2016, OMICS Publishing Group

    Dr Felix-Martin Werner

  24. Current Treatment of Schizoaffective Disorder According to a Neural Network

    Article • Journal of Cytology & Histology, January 2016, OMICS Publishing Group

    Dr Felix-Martin Werner

  25. Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs

    Article • Current Drug Therapy, December 2015, Bentham Science Publishers

    Dr Felix-Martin Werner

  26. New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine

    Article • Therapeutics and Clinical Risk Management, November 2015, Dove Medical Press

    Dr Felix-Martin Werner

  27. Methicillin-Resistant Staphylococcus aureus: Treatment with Cultures of Non Drug-Resistant Staphylococcus epidermidis

    Article • Recent Patents on Anti-Infective Drug Discovery, October 2015, Bentham Science Publishers

    Dr Felix-Martin Werner

  28. Review: Classical neurotransmitters and neuropeptides involved in generalized epilepsy in a multi-neurotransmitter system: How to improve the antiepileptic effect?

    Article • Epilepsy & Behavior, March 2015, Elsevier

    Dr Felix-Martin Werner

  29. Treatment of Psychotic Symptoms in ParkinsonÂ’s Disease

    Article • Journal of Cytology & Histology, January 2015, OMICS Publishing Group

    Dr Felix-Martin Werner

  30. Treatment of Bipolar Disorder according to a Neural Network

    Article • Journal of Cytology & Histology, January 2015, OMICS Publishing Group

    Dr Felix-Martin Werner

  31. Might Combined GABAA Agonists and NMDA Antagonists have a Therapeutic and maybe a Prophylactic Effect in Alzheimer’s and Parkinson’s Disease?

    Article • Journal of Cytology & Histology, January 2015, OMICS Publishing Group

    Dr Felix-Martin Werner

  32. Neuropeptides and Neurotransmitters Involved in Generalized Epilepsy: How Can the Antiepileptic Effect be Improved?

    Article • Journal of Neurology & Neurophysiology, January 2015, OMICS Publishing Group

    Dr Felix-Martin Werner

  33. Classical Neurotransmitters and Neuropeptides Involved in Schizophrenia: How to Improve the Therapeutic Effect of the Antipsychotic Drugs

    Article • Journal of Pharmacy and Pharmacology, October 2014, David Publishing Company

    Dr Felix-Martin Werner

  34. Therapeutic and adverse effects of antipsychotic drugs

    Article • Expert Opinion on Drug Safety, June 2014, Informa Healthcare

    Dr Felix-Martin Werner

  35. Efficacy of Novel Antidepressant Drugs in Comparison to Conventional Antidepressant Drugs

    Article • Journal of Clinical Case Reports, January 2014, OMICS Publishing Group

    Dr Felix-Martin Werner

  36. Neurotransmitter and neuropeptide alterations in major depression.

    Article • Current Medicinal Chemistry, November 2013, Bentham Science Publishers

    Dr Felix-Martin Werner

  37. Neurotransmitter and neuropeptide alterations in schizophrenia in the brain regions involved

    Article • Current Drug Therapy, September 2013, Bentham Science Publishers

    Dr Felix-Martin Werner

  38. Altered neurotransmitters and neuropeptides in the brain regions involved in major depression

    Article • International Journal of Neuroscience, May 2010, Taylor & Francis

    Dr Felix-Martin Werner